Table 1 Baseline characteristics and comorbidities
From: Cost of illness and economic burden of chronic lymphocytic leukemia
CLL group | Control group | ||||
|---|---|---|---|---|---|
Mean | STD | Mean | STD | p-Value | |
Baseline characteristics | |||||
Age | 66.1 | (13.2) | 66.1 | (13.2) | |
Sex (male = 1) | 66.9% | 66.9% | |||
Mortality (per calendar year) | 4.9% | 1.7% | |||
Elixhauser comorbidity groups | |||||
Congestive heart failure | 12.7% | 10.3% | <.001 | ||
Cardiac arrhythmias | 20.9% | 18.4% | <.001 | ||
Valvular disease | 10.3% | 8.5% | <.001 | ||
Pulmonary circulation disorders | 3.0% | 2.0% | <.001 | ||
Peripheral vascular disorders | 13.2% | 11.8% | <.001 | ||
Hypertension uncomplicated | 52.6% | 53.3% | 0.214 | ||
Hypertension complicated | 9.1% | 8.4% | 0.032 | ||
Paralysis | 2.4% | 2.1% | 0.030 | ||
Other neurological disorders | 4.5% | 4.4% | 0.469 | ||
Chronic pulmonary disease | 23.8% | 18.4% | <.001 | ||
Diabetes uncomplicated | 19.5% | 18.0% | 0.001 | ||
Diabetes complicated | 8.0% | 7.1% | 0.003 | ||
Hypothyroidism | 9.2% | 7.6% | <.001 | ||
Renal failure | 10.4% | 7.9% | <.001 | ||
Liver disease | 14.1% | 12.2% | <.001 | ||
Peptic ulcer disease excluding bleeding | 2.4% | 2.0% | 0.010 | ||
AIDS/HIV | 0.2% | 0.1% | <.001 | ||
Lymphoma | 27.7% | 0.8% | <.001 | ||
Metastatic cancer | 9.6% | 3.2% | <.001 | ||
Solid tumor without metastasis | 22.9% | 17.1% | <.001 | ||
Rheumatoid arthritis/collagen vascular diseases | 8.1% | 6.6% | <.001 | ||
Coagulopathy | 11.2% | 3.4% | <.001 | ||
Obesity | 9.6% | 10.2% | 0.062 | ||
Weight loss | 3.2% | 1.1% | <.001 | ||
Fluid and electrolyte disorders | 9.3% | 4.5% | <.001 | ||
Blood loss anemia | 0.5% | 0.4% | 0.030 | ||
Deficiency anemias | 4.5% | 2.9% | <.001 | ||
Alcohol abuse | 1.7% | 2.2% | 0.003 | ||
Drug abuse | 0.5% | 0.4% | 0.136 | ||
Psychoses | 1.0% | 0.8% | 0.018 | ||
Depression | 17.3% | 13.4% | <.001 | ||
Elixhauser score | 10.0 | (10.5) | 5.2 | (7.9) | <.001 |